Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
June-2017 Volume 13 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2017 Volume 13 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells

  • Authors:
    • Shigeaki Sunada
    • Ian M. Cartwright
    • Hirokazu Hirakawa
    • Akira Fujimori
    • Mitsuru Uesaka
    • Takamitsu A. Kato
  • View Affiliations / Copyright

    Affiliations: Department of Nuclear Engineering and Management, School of Engineering, The University of Tokyo, Tokyo 113‑8656, Japan, Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO 80523, USA, Department of Basic Medical Sciences for Radiation Damage, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba 263‑8555, Japan
  • Pages: 4911-4916
    |
    Published online on: April 21, 2017
       https://doi.org/10.3892/ol.2017.6072
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Spread-out Bragg peak (SOBP) C ions have been used clinically in charged particle radiation therapy for years. An SOBP beam consists of various monoenergetic Bragg peaks; however, the biological effect of irradiation with an SOBP beam track has not been well‑studied. In order to determine the clinically prospective molecular targets, radiosensitivity to the beam track in DNA repair deficient cell lines was investigated. A total of four distinct Chinese hamster ovary (CHO) cell lines, including CHO10B2 (wild‑type), V3 (protein kinase DNA‑activated catalytic polypeptide deficient), 51D1 (RAD51 paralog D deficient) and PADR9 [poly(ADP‑ribose) polymerase (PARP) deficient], were irradiated with gamma‑rays, C ions (290 MeV/n) and Fe ions (500 MeV/n), in order to compare cellular lethality. An OptiCell™ culture system was used to evaluate the lethality at distinct depths of SOBP C ions. Relative biological effectiveness (RBE) values of C ions (linear energy transfer (LET), 13 and 70 keV/µm) and Fe ions (LET, 200 keV/µm) were calculated from cell survival using colony formation assay with standard cell dishes. All cell lines exhibited similar sensitivity to 70 keV/µm C ions and 200 keV/µm Fe ions. Furthermore, V3 cells did not exhibit increased sensitivity to high LET C ions and Fe ions, compared with low LET gamma‑rays and C ions, and 51D1 cells irradiated with 13 keV/µm C ions exhibited relatively high RBE values among the tested cell lines. Conversely, PADR9 cells exhibited low RBE values for 13 keV/µm C ions and high RBE values for 70 keV/µm C ions. Obtained using the OptiCell system, the survival fractions in the SOBP region were uniform for wild‑type and PADR9 cells. Conversely, V3 and 51D1 cells exhibited decreased cell death in the distal region of the SOBP. These results indicated that PARP is a more effective target for clinical beam therapy, compared with the non‑homologous end joining repair and homologous recombination repair pathways. PARP deficiency may be an optimal target for C ion therapy and the results of the present study may contribute to the development of a more effective heavy ion radiation therapy.

Introduction

Heavy ion radiation therapy began in the 1970s in the USA as a more efficient radiation therapy compared with classical X-ray therapy (1,2). Heavy ion therapy is gaining prevalence, and has been increasingly utilized in Japan, China, Germany and Italy (1,2). Heavy ions exhibit three advantageous cancer cell killing characteristics when compared with X-rays. Heavy ions exhibit a more efficient dose distribution in cancer tissues due to the Bragg peak. The phenomenon allows for the majority of the dose to be deposited within the cancer tissues, avoiding unnecessary radiation exposure to normal tissues. In addition, heavy ions form complex DNA lesions within the cell due to the large amount of energy deposited during particle/DNA interactions. Heavy ions are able to produce more complex DNA lesions compared with X-rays and gamma-rays (1,2). Complex DNA damage lesions are more difficult to repair, compared with the simple DNA damage lesions frequently observed following irradiation with X-rays and gamma-rays (3). Furthermore, heavy ions have a low oxygen enhancement ratio (3). Heavy ions are more effective at cell killing under hypoxic conditions when compared with X-rays and protons (4).

Currently, spread-out Bragg peak (SOBP) C ions are used in heavy ion radiation therapy (1,2). An SOBP beam consists of various monoenergetic Bragg peak beams to extend the Bragg peak region to effectively cover the entire cancerous area and lead to tumor cell death (5). SOBP C ions have been demonstrated to be effective in the clinic (1,2); however, the biological effect of the beam track has not been well-studied. In particular, the linear energy transfer (LET) values in the SOBP region are increased compared with conventionally used radiation, including X-rays and gamma-rays, and these values increase with the depth of the beam track (1,2). Due to this, the quality of the DNA lesion at each depth point is regarded as being distinct (1,2). It has been reported that high LET irradiation requires distinct DNA repair mechanisms compared with low LET irradiation, and these differences are specifically observed in the two primary DNA double strand breaks (DSB) repair pathways: Homologous recombination (HR) and non-homologous end joining (NHEJ) (6,7). However, the differences between high and low LET irradiation remain to be completely elucidated.

In the present study, the radiosensitivities of four Chinese hamster ovary (CHO) cell lines to SOBP C ions were evaluated to investigate how assorted DNA repair proteins responded to various LET values, and the subsequent effect on NHEJ, HR and single strand break repair (8,9). The present study utilized the OptiCell™ system, previously established by the authors (10,11), to investigate the effects of distinct LET-induced radiosensitivities. The OptiCell system enables the biological effect to be perceived at each depth point of the beam path, allowing for a comprehensive analysis of the SOBP beam. It was observed that only the single strand break repair deficient cells demonstrated LET-dependent radiosensitivity in the SOBP region. The results of the present study may affect the future development of heavy ion radiation therapy.

Materials and methods

Cell culture

The CHO10B2 (wild-type), V3 (protein kinase DNA-activated catalytic polypeptide deficient) (12) and PADR9 [poly(ADP-ribose) polymerase (PARP) deficient] (13,14) cells were donated by Dr Joel Bedford (Colorado State University, Fort Collins, CO, USA). The 51D1 (RAD51 paralog D deficient) cells were donated by Dr Larry Thompson (Lawrence Livermore National Laboratory, Livermore, CA, USA) (15). All cell lines were grown in minimum essential medium α (Wako Pure Chemical Indsutries, Ltd., Osaka, Japan) supplemented with 10% (v/v) heat-inactivated fetal bovine serum (Sigma-Aldrich; Merck Millipore, Darmstadt, Germany), and 1% penicillin, streptomycin and Fungizone solution (antibiotic-antimycotic; Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA), at 37°C in an atmosphere containing 5% CO2. Exponentially growing log phase cells were used in the present study.

Irradiation

Irradiation with gamma-rays was performed at Colorado State University using a J.L. Shepherd Model Mark I-68 nominal 6000 Ci 137Cs irradiator (J.L. Shepherd and Associates, San Fernando, CA, USA) at room temperature and at a dose rate of 2.5 Gy/min (16). Heavy ion irradiation was performed at the National Institute of Radiological Sciences (Chiba, Japan). C ions and Fe ions were accelerated to 290 and 500 MeV/n, respectively, using the Heavy Ion Medical Accelerator in Chiba (HIMAC). Dose rates for C ions and Fe ions were set at 1 Gy/min. C ions and Fe ions had LET values of 13 and 200 keV/µm upon entrance. For monoenergetic beam irradiation, 13 and 70 keV/µm C ions, and 200 keV/µm Fe ions, were used. Monoenergetic C ions with an LET of 70 keV/µm were obtained by Lucite attenuation (17). For OptiCell (Thermo Fisher Scientific, Inc.) irradiation, C ions were accelerated to 290 MeV/n initial energy and spread out with a ridge filter to produce an SOBP of width 6 cm (18).

Cell survival assay using standard cell culture dishes

Cell survival assay using standard cell culture dishes was performed as follows. For the gamma-ray irradiated cell survival assay, exponentially growing cultured cells were irradiated as described above and plated onto P-60 cell culture dishes at a density designed to yield ~100 viable colony-forming cells per P-60 dish. For the heavy ion irradiated cell survival assay, 4 ml culture medium containing 500 cells was plated onto each P-60 dish ~3 h prior to irradiation with C and Fe ions, as described above. All samples were incubated at 37°C for between 7 and 8 days, until cells had formed substantially sized colonies visible by eye. Surviving colonies were rinsed with 0.9% NaCl, fixed with 100% ethanol and stained using 0.1% crystal violet at room temperature. Each colony consisting of >50 cells was scored as a surviving colony. Cell survival curves were constructed using GraphPad Prism software (version 6; GraphPad Software, Inc., La Jolla, CA, USA) and linear quadratic regression. Three independent experiments were conducted. The D10 values, which represent doses required to achieve 10% survival, were obtained from each survival curve using GraphPad Prism software.

Cell survival assay using OptiCell culture chamber

The cell survival assay using OptiCell culture chambers was performed as described previously (10,11). For the OptiCell survival assay following irradiation with SOBP C ions, 10 ml of culture medium containing between 400 and 600 cells was added to each chamber ~3 h prior to irradiation. In order to deliver a uniform cell killing effect to each cell line, 4 Gy was delivered to CHO10B2 and PADR9 cells, 2 Gy was delivered to V3 cells, and 3 Gy was delivered to 51D1 cells at a depth of 0 cm. Immediately following irradiation, all samples were incubated for between 7 and 8 days as described above. Each colony consisting of >50 cells was scored as a surviving colony. At least two independent experiments were performed using each cell line. The SOBP slope values, which represent the isobiological cell killing effect of SOBP irradiation, were calculated as a linear regression with survival fraction data at depths of between 8 and 14 cm. The proximal and distal SOBP regions were defined as between 8 and 11 cm, and 11 and 14 cm, respectively, and used in the comparison of cell killing effects.

Statistical analysis

All data were analyzed using GraphPad Prism software. Values are presented as the mean ± standard error of the means. Statistical comparison was performed using an unpaired two tailed t-test. P<0.05 was considered to indicate a statistically significant difference.

Results

Cell survival in low and high LET-irradiated DNA repair deficient-CHO cell lines

Cell survival in DNA repair deficient-CHO cell lines was evaluated to assess the response to gamma-rays, C ions (LET, 13 and 70 keV/µm) and Fe ions (LET, 200 keV/µm; Fig. 1). CHO10B2 and PADR9 cells were observed to be radioresistant cells. The survival curves following gamma-ray irradiation were linear quadratic. Although CHO10B2 and PADR9 exhibited moderate sensitivity to C ions (LET, 13 keV/µm), they exhibited increased sensitivity to C ions (LET, 70 keV/µm) and Fe ions (LET, 200 keV/µm) compared with gamma-rays. At the high LET radiation exposure, the cell survival curves of CHO10B2 and PADR9 cells were exponential. V3 cells were the most radiosensitive cells among tested cell lines and exhibited exponential cell survival curves. The radiosensitivities of V3 cells were similar for the low LET and high LET radiation. 51D1 cells exhibited intermediate radiosensitivity compared with the four cell lines. 51D1 cells exhibited relatively increased radiosensitivity to C ions (LET, 13 keV/µm) compared with the other cells.

Figure 1.

Cell survival in DNA repair deficient-CHO cell lines. The survival fractions of (A) CHO10B2, (B) V3, (C) 51D1 and (D) PADR9 cells, following irradiation with gamma-rays, C ions (LET, 13 and 70 keV/µm) and Fe ions (LET, 200 keV/µm), were determined using colony formation assays. Closed circles indicate gamma-rays, open squares indicate C ions LET 13 keV/µm, open triangles indicate C ions LET 70 keV/µm, and closed triangles indicate Fe ions 200 keV/µm. Values are presented as the mean ± standard error of the mean of three independent experiments. CHO, Chinese hamster ovary; LET, linear energy transfer; DNA-PKcs, protein kinase DNA-activated catalytic polypeptide; Rad51D, RAD51 paralog D; PARP, poly(ADP-ribose) polymerase.

In order to quantitatively evaluate the responses, the relative biological effectiveness (RBE) values of the 290 MeV/n C ions (LET, 13 and 70 keV/µm) and 500 MeV/n Fe ions were calculated based on the D10 values (Table I). Gamma-rays were adopted as the standard radiation. The C (LET, 13 and 70 keV/µm) and Fe ions exhibited an RBE of 1.54, 2.76 and 2.93 in CHO10B2 cells, 1.37, 1.50 and 1.19 in V3 cells, 1.73, 2.50 and 2.31 in 51D1 cells, and 1.38, 2.66 and 2.66 in PADR9 cells, respectively. The cell lines exhibited similar radiosensitivity, in terms of RBE values, following irradiation with 70 keV/µm C ions compared with irradiation with the Fe ions.

Table I.

RBE values calculated from D10 values for CHO wild type and DNA repair deficient mutants.

Table I.

RBE values calculated from D10 values for CHO wild type and DNA repair deficient mutants.

Cell line, RBE value
Heavy ionCHO10B2V351D1PADR9
C ions (13 keV/µm)1.541.371.731.38
C ions (70 keV/µm)2.761.52.52.66
Fe ions (200 keV/µm)2.931.192.312.66

[i] RBE, relative biological effectiveness; CHO, Chinese hamster ovary.

Cell survival following irradiation with SOBP C ions compared with depth

The cell survival assay using the OptiCell™ culture system following irradiation with SOBP C ions was performed in CHO10B2, V3, 51D1 and PADR9 cells. SOBP C ions were delivered at depths of between 8 and 14 cm (Fig. 2). At a depth of 1.4 cm, the survival fraction was 0.30 for CHO10B2, 0.37 for V3, 0.21 for 51D1 and 0.43 for PADR9. As observed in all cell lines, the survival fraction decreased gradually from 1.4 cm to a depth of 8 cm and rapidly increased at a depth of 14 cm. In the SOBP region, the minimum survival fraction was 0.050 for CHO10B2, 0.140 for V3, 0.048 for 51D1 and 0.077 for PADR9. When compared with the entrance region, the SOBP region exhibited between a 5- and 6-fold increase in cell death in the CHO10B2 (P=0.002) and PADR9 (P=0.037) cells, and an ~2.7-fold increase in cell death in the V3 (P=0.023) and 51D1 cells (P=0.001; Fig. 3).

Figure 2.

Dose and LET distribution of C beam path. Dose distribution values for the (A) monoenergetic and (B) SOBP C ions, and (C) LET distribution values for the SOBP C ions, were calculated at increasing depth. The SOBP region was defined as a depth of between 8 and 14 cm. LET, linear energy transfer; SOBP, spread-out Bragg peak.

Figure 3.

The survival fractions of (A) CHO10B2, (B) V3, (C) 51D1 and (D) PADR9 cells irradiated with SOBP C ions were determined using OptiCell™ colony formation assays at varying depths. Values are presented as the mean ± standard error of the mean of at least two independent experiments. The SOBP region was defined as a depth of between 8 and 14 cm. CHO, Chinese hamster ovary; SOBP, spread-out Bragg peak; DNA-PKcs, protein kinase DNA-activated catalytic polypeptide; Rad51D, RAD51 paralog D; PARP, poly(ADP-ribose) polymerase.

SOBP slope values in the SOBP region

Comparing the profile of the SOBP region survival fractions of CHO10B2 and PADR9 cells with those of V3 and 51D1 cells, the V3 and 51D1 cells exhibited increased survival at the distal SOBP region. In order to evaluate the cytotoxic efficiency of the SOBP region, SOBP slope values were calculated (Fig. 4). The values of each cell line were 0.017 (CHO10B2), 0.059 (V3), 0.046 (51D1) and ~0 (PADR9). SOBP slope values nearing 0 suggest isobiological cell death within the SOBP region. Only the V3 cells exhibited a statistically significant increase in cell death to proximal SOBP compared with distal SOBP (P=0.027; Fig. 4B). 51D1 cells exhibited a marked trend of increased radioresistance to distal SOBP compared with proximal SOBP (P=0.052; Fig. 4C). CHO10B2 (P=0.947; Fig. 4A) and PADR9 (P=0.906; Fig. 4D) did not exhibit significant differences between proximal and distal SOBP cytotoxicity.

Figure 4.

SOBP slope values of the cell survival curves in the SOBP region. The slope values of (A) CHO10B2, (B) V3, (C) 51D1 and (D) PADR9 cells irradiated with SOBP C ions were calculated from the survival fraction data from the OptiCell™ culture system at depths of between 8 and 14 cm. Values are presented as the mean ± standard error of the mean from at least two independent experiments. CHO, Chinese hamster ovary; SOBP, spread-out Bragg peak; DNA-PKcs, protein kinase DNA-activated catalytic polypeptide; Rad51D, RAD51 paralog D; PARP, poly(ADP-ribose) polymerase.

Discussion

In the present study, the biological effect of irradiation with the SOBP beam region of C ions was assessed using the OptiCell™ culture system, as reported previously (10,11), and used to construct a three-dimensional geometric in vitro experiment. The results of the present study demonstrated that a 6 cm wide SOBP C beam consists of various monoenergetic Bragg peak beams, which cause rapid build-up of radiation dosage at a depth of 8 cm, a gradual decrease until the proximal boundary and a rapid decrease at 14 cm. Conversely, LET gradually increases up to a depth of 14 cm. The combination of these dosages and LET distributions enables the isobiological killing of cells within the SOBP region. However, the LET distribution in the SOBP region is wider compared with monoenergetic beams (5). The biological effects from irradiation with monoenergetic ions and SOBP with the identical average LET were distinct (5). Therefore, monoenergetic ions cannot be used to estimate the biological effects of irradiation with SOBP with identical average LET values.

LET-dependent radiosensitivities were studied in wild-type and DNA repair deficient-CHO cell lines in the present study. Following the construction of cell survival curves, wild-type and DNA repair deficient-cell lines exhibited distinct biological effects when exposed to high LET radiation. RBE values were demonstrated to increase as LET increases in wild-type cells, while this association between LET level and RBE value was not observed in V3 cells. It was confirmed that radiosensitivity is dose-dependent in NHEJ-deficient cells but not LET-dependent, as was previously demonstrated (17,19). Therefore, disruption of NHEJ repair may not be the optimum strategy for the enhancement of tumor control using high LET radiation. The 51D1 cells exhibited increased radiosensitivity to irradiation with 13 keV/µm C ions, which represents the entrance region of the C ion beam. C ions with LET of 13 keV/µm may be exposed to the normal tissues that surround tumor tissues. Unless tumors are selectively targeted by HR inhibitors, it may cause certain side effects in normal tissues. Conversely, as PADR9 cells exhibited a shift in sensitivity to high LET radiation from 13 to 70 keV/µm C ions, elevated side effects in normal tissues from PARP inhibition may be limited. This high LET-specific sensitivity is an attractive target for C ion radiotherapy. In particular, PARP is a repair protein associated with single strand break repair (8,9). It has also been reported that PARP may serve a role in DSB repair (20). As high LET radiation produces complex types of DNA damage, which are a mixture of single strand break and DSB, PARP may be a promising therapeutic target (21–23). The results of the present study appear to be in accordance with the PARP inhibitor-induced sensitization with high LET radiation (24), and indicate PARP inhibition may be a potential target for heavy ion radiation therapy.

The SOBP beam was originally designed to achieve uniform cytotoxicity in human salivary gland (HSG) cells (25). In the present study, CHO wild-type cells exhibited similar isobiological cell killing effects within the SOBP region compared with HSG cells (25). The SOBP region had distinct impacts on each cell line and the SOBP slopes between depths of 8 and 14 cm were calculated. Compared with the slope value of the wild-type cells, the decreased slope values of the other cell lines demonstrated that the cells were sensitive to radiation in an LET-dependent manner. These results indicated that DNA repair deficiency selectively sensitizes cells to high LET radiation. The SOBP slope value of PADR9 cells was the lowest (~0) followed by that of CHO10B2 (0.017), 51D1 (0.046) and V3 (0.059) cells (Fig. 4). The order of slope values and differences in RBE values among the cell lines were associated. As hypothesized following the construction of cell survival curves, V3 cells exhibited the highest slope value among the cell lines due to their low RBE value following irradiation to high LET radiation. HR-deficient 51D1 cells exhibited increased slope values compared with the wild-type cells. Multiple reports suggested that damage produced by high LET radiation is repaired by HR with partial suppression of the NHEJ signaling pathway (6,7). The results of the present study suggested that inhibiting NHEJ or HR may lead to non-uniform cytotoxicity within the C ion 6 cm SOBP region. Although disruptions of these signaling pathways will result in increased cytotoxicity in the SOBP region, the current SOBP design obtained from the HSG cell results cannot be directly applied clinically to radiotherapy. Conversely, PADR9 cells exhibited isobiological cell killing effects within the SOBP region. The results of the present study suggest that PARP is an effective inhibitory target to complement radiotherapy.

In conclusion, the radiosensitivity of DNA repair deficient-CHO cell lines to high and low LET was investigated, and the isobiological cell killing effects in the SOBP region of the radiation beam were evaluated using an OptiCell system. PARP inhibition was identified to potentially be an optimal target to complement radiotherapy, and the results of the present study may contribute to the development of more effective heavy ion radiation therapies.

Acknowledgements

The authors of the present study would like to thank Mr. T. Inoue and Mr. Y. Hao (The University of Tokyo, Tokyo, Japan) for technical assistance, and support from National Institute of Radiological Sciences-HIMAC. The present study was partially supported by the Dr Akiko M. Ueno Radiobiology Fund, the Japan Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research on Innovative Areas (grant no. 15H05935) and the Japan Society for the Promotion of Science research fellowship (grant no. 15J09331).

References

1 

Durante M and Loeffler JS: Charged particles in radiation oncology. Nat Rev Clin Oncol. 7:37–43. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Marx V: Cancer treatment: Sharp shooters. Nature. 508:133–138. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Okayasu R: Repair of DNA damage induced by accelerated heavy ions-A mini review. Int J Cancer. 130:991–1000. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Hirayama R, Furusawa Y, Fukawa T and Ando K: Repair Kinetics of DNA-DSB induced by X-rays or C Ions under oxic and hypoxic conditions. J Radiat Res. 46:325–332. 2005. View Article : Google Scholar : PubMed/NCBI

5 

Belli M, Bettega D, Calzolari P, Cherubini R, Cuttone G, Durante M, Esposito G, Furusawa Y, Gerardi S, Gialanella G, et al: Effectiveness of monoenergetic and spread-out bragg peak carbon-ions for inactivation of various normal and tumour human cell lines. J Radiat Res. 49:597–607. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Okayasu R, Okada M, Okabe A, Noguchi M, Takakura K and Takahashi S: Repair of DNA damage induced by accelerated heavy ions in mammalian cells proficient and deficient in the non-homologous end-joining pathway. Radiat Res. 165:59–67. 2006. View Article : Google Scholar : PubMed/NCBI

7 

Yajima H, Fujisawa H, Nakajima NI, Hirakawa H, Jeggo PA, Okayasu R and Fujimori A: The complexity of DNA double strand breaks is a critical factor enhancing end-resection. DNA Repair (Amst). 12:936–946. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Benjamin RC and Gill DM: Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks. J Biol Chem. 255:10502–10508. 1980.PubMed/NCBI

9 

Benjamin RC and Gill DM: ADP-ribosylation in mammalian cell ghosts. Dependence of poly(ADP-ribose) synthesis on strand breakage in DNA. J Biol Chem. 255:10493–10501. 1980.PubMed/NCBI

10 

Genet SC, Maeda J, Fujisawa H, Yurkon CR, Fujii Y, Romero AM, Genik PC, Fujimori A, Kitamura H and Kato TA: Comparison of cellular lethality in DNA repair-proficient or -deficient cell lines resulting from exposure to 70 MeV/n protons or 290 MeV/n C ions. Oncol Rep. 28:1591–1596. 2012.PubMed/NCBI

11 

Fujisawa H, Genik PC, Kitamura H, Fujimori A, Uesaka M and Kato TA: Comparison of human chordoma cell-kill for 290 MeV/n C ions versus 70 MeV protons in vitro. Radiat Oncol. 8:912013. View Article : Google Scholar : PubMed/NCBI

12 

Whitmore GF, Varghese AJ and Gulyas S: Cell cycle responses of two X-ray sensitive mutants defective in DNA repair. Int J Radiat Biol. 56:657–665. 1989. View Article : Google Scholar : PubMed/NCBI

13 

MacLaren RA, Witmer MV, Richardson E and Stamato TD: Isolation of Chinese hamster ovary cells with reduced poly(ADP-ribose) polymerase activity. Mutat Res. 231:265–274. 1990. View Article : Google Scholar : PubMed/NCBI

14 

Witmer MV, Aboul-Ela N, Jacobson MK and Stamato TD: Increased sensitivity to DNA-alkylating agents in CHO mutants with decreased poly(ADP-ribose) polymerase activity. Mutat Res. 314:249–260. 1994. View Article : Google Scholar : PubMed/NCBI

15 

Hinz JM, Tebbs RS, Wilson PF, Nham PB, Salazar EP, Nagasawa H, Urbin SS, Bedford JS and Thompson LH: Repression of mutagenesis by Rad51D-mediated homologous recombination. Nucleic Acids Res. 34:1358–1368. 2006. View Article : Google Scholar : PubMed/NCBI

16 

Sunada S, Fujisawa H, Cartwright IM, Maeda J, Brents CA, Mizuno K, Aizawa Y, Kato TA and Uesaka M: Monoglucosyl-rutin as a potential radioprotector in mammalian cells. Mol Med Rep. 10:10–14. 2014.PubMed/NCBI

17 

Mcmillan DD, Maeda J, Bell JJ, Genet MD, Phoonswadi G, Mann KA, Kraft SL, Kitamura H, Fujimori A, Yoshii Y, et al: Validation of 64 Cu-ATSM damaging DNA via high-LET Auger electron emission. J Radiat Res. 56:784–791. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Maeda J, Cartwright IM, Haskins JS, Fujii Y, Fujisawa H, Hirakawa H, Uesaka M, Kitamura H, Fujimori A, Thamm DH and Kato TA: Relative biological effectiveness in canine osteosarcoma cells irradiated with accelerated charged particles. Oncol Lett. 12:1597–1601. 2016.PubMed/NCBI

19 

Weyrather WK, Ritter S, Scholz M and Kraft G: RBE for carbon track-segment irradiation in cell lines of differing repair capacity. Int J Radiat Biol. 75:1357–1364. 1999. View Article : Google Scholar : PubMed/NCBI

20 

Beck C, Robert I, Reina-San-Martin B, Schreiber V and Dantzer F: Poly(ADP-ribose) polymerases in double-strand break repair: Focus on PARP1, PARP2 and PARP3. Exp Cell Res. 329:18–25. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Urushibara A, Shikazono N, O'Neill P, Fujii K, Wada S and Yokoya A: LET dependence of the yield of single-, double-strand breaks and base lesions in fully hydrated plasmid DNA films by 4He(2+) ion irradiation. Int J Radiat Biol. 84:23–33. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Taucher-Scholz G and Kraft G: Influence of radiation quality on the yield of DNA strand breaks in SV40 DNA irradiated in solution. Radiat Res. 151:595–604. 1999. View Article : Google Scholar : PubMed/NCBI

23 

Taucher-Scholz G, Stanton JA, Schneider M and Kraft G: Induction of DNA breaks in SV40 by heavy ions. Adv Space Res. 12:73–80. 1992. View Article : Google Scholar : PubMed/NCBI

24 

Hirai T, Shirai H, Fujimori H, Okayasu R, Sasai K and Masutani M: Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation. Cancer Sci. 103:1045–1050. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Kagawa K, Murakami M, Hishikawa Y, Abe M, Akagi T, Yanou T, Kagiya G, Furusawa Y, Ando K, Nojima K, et al: Preclinical biological assessment of proton and carbon ion beams at Hyogo ion beam medical center. Int J Radiat Oncol Biol Phys. 54:928–938. 2002. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Sunada S, Cartwright IM, Hirakawa H, Fujimori A, Uesaka M and Kato TA: Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells. Oncol Lett 13: 4911-4916, 2017.
APA
Sunada, S., Cartwright, I.M., Hirakawa, H., Fujimori, A., Uesaka, M., & Kato, T.A. (2017). Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells. Oncology Letters, 13, 4911-4916. https://doi.org/10.3892/ol.2017.6072
MLA
Sunada, S., Cartwright, I. M., Hirakawa, H., Fujimori, A., Uesaka, M., Kato, T. A."Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells". Oncology Letters 13.6 (2017): 4911-4916.
Chicago
Sunada, S., Cartwright, I. M., Hirakawa, H., Fujimori, A., Uesaka, M., Kato, T. A."Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells". Oncology Letters 13, no. 6 (2017): 4911-4916. https://doi.org/10.3892/ol.2017.6072
Copy and paste a formatted citation
x
Spandidos Publications style
Sunada S, Cartwright IM, Hirakawa H, Fujimori A, Uesaka M and Kato TA: Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells. Oncol Lett 13: 4911-4916, 2017.
APA
Sunada, S., Cartwright, I.M., Hirakawa, H., Fujimori, A., Uesaka, M., & Kato, T.A. (2017). Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells. Oncology Letters, 13, 4911-4916. https://doi.org/10.3892/ol.2017.6072
MLA
Sunada, S., Cartwright, I. M., Hirakawa, H., Fujimori, A., Uesaka, M., Kato, T. A."Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells". Oncology Letters 13.6 (2017): 4911-4916.
Chicago
Sunada, S., Cartwright, I. M., Hirakawa, H., Fujimori, A., Uesaka, M., Kato, T. A."Investigation of the relative biological effectiveness and uniform isobiological killing effects of irradiation with a clinical carbon SOBP beam on DNA repair deficient CHO cells". Oncology Letters 13, no. 6 (2017): 4911-4916. https://doi.org/10.3892/ol.2017.6072
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team